Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1998
12/15/1998US5849943 Stilbene derivatives useful as cyclooxygenase-2 inhibitors
12/15/1998US5849919 Fused benzeneoxyacetic acid derivatives which have PGI2 receptor anonist activity
12/15/1998US5849865 Peptides for altering bone resorption, angiogenesis and restenosis
12/15/1998US5849860 Polyethylene-protein conjugates
12/15/1998US5849794 Guanylhydrazones and their use to treat inflammatory conditions
12/15/1998US5849793 HIV matrix protein tyrosine position 29 pocket binders
12/15/1998US5849792 Storage-stable prostaglandin compositions
12/15/1998US5849787 Hypercholesterolemia therapeutic agent
12/15/1998US5849784 Cyclic sulfone containing retroviral protease inhibitors
12/15/1998US5849777 Cell differentiation induction with mevalonate and mevalonolactone derivatives
12/15/1998US5849775 Substituted benzoylguanidines process for their preparation, their use as a medicament or diagnostic, and pharmaceutical containing them
12/15/1998US5849771 Phosphorylated nitrone derivatives, method for preparing same, and compositions containing said derivatives
12/15/1998US5849770 Tri-substituted phenyl derivatives useful as PDE IV inhibitors
12/15/1998US5849761 Peripherally active anti-hyperalgesic opiates
12/15/1998US5849760 2-(arylalkenyl)azacycloalkane derivatives as ligands for sigma receptors
12/15/1998US5849753 Pyridyl imidazole derivatives and processes for the preparation thereof
12/15/1998US5849746 Substituted 1,4-piperazine-heteroaryl derivatives as 5-HT1D receptor agonists
12/15/1998US5849745 N-benzylpiperazine compounds
12/15/1998US5849744 Pyrrolyl tetrahydrobenzoquinoxaline diones, their preparation and use as glutamate receptor antagonist
12/15/1998US5849739 5-arylindole derivatives
12/15/1998US5849736 Isoxazoline and isoxazole fibrinogen receptor antagonists
12/15/1998US5849726 Anhydrous alendronate monosodium salt formulations
12/15/1998US5849710 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
12/15/1998US5849709 Saccharopeptides and derivatives thereof
12/15/1998US5849705 Method for the treatment of Schwann cells in vivo
12/15/1998US5849701 Peptide inhibitors of fibronectin and related collagen-binding proteins
12/15/1998US5849580 Nucleic acid encoding a NF-κB activation regulatory protein, IκBβ
12/15/1998US5849535 Human growth hormone variants
12/15/1998US5849507 Methods to diagnose thrombosis by measuring activation peptide
12/15/1998US5849506 Reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
12/15/1998US5849337 Method of enhancing magnesium absorption and prevention of atherosclerosis
12/15/1998US5849324 Use of indigestible oligosaccharides to reduce the incidence of otitis media in humans
12/15/1998US5849312 Therapeutic/cosmetic compositions comprising bradykinin antagonist for treating sensitive human skin
12/15/1998US5849283 Human interleukin-6 receptor antagonists
12/15/1998US5849261 Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
12/15/1998CA2163667C Imidazole lipoxygenase inhibitors
12/15/1998CA2163534C Inhibition of hair growth
12/15/1998CA2160462C Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
12/15/1998CA2144513C Morphogen-induced periodontal tissue regeneration
12/15/1998CA2092653C Substituted pyrrolidine derivatives as hiv protease inhibitors
12/15/1998CA1340247C Choline salts of arylmethylenyl thiazolidinones and oxazolidinones
12/15/1998CA1340205C Alkylene diamines
12/13/1998CA2240312A1 .beta.-adrenergic agonists to reduce a wasting condition
12/11/1998CA2233584A1 7tm receptor hlwar77
12/10/1998WO1998055639A2 Recombinant adenoviral vectors comprising a splicing sequence
12/10/1998WO1998055622A1 Preparation of glycosylated tumor necrosis factor
12/10/1998WO1998055621A1 Ntn-2 member of tnf ligand family
12/10/1998WO1998055619A1 Anti-gpiib/iiia recombinant antibodies
12/10/1998WO1998055617A1 Translational regulator initiation factor 4e-binding protein
12/10/1998WO1998055615A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
12/10/1998WO1998055613A1 Zinc ring protein
12/10/1998WO1998055609A1 Inhibitors of dna immunostimulatory sequence activity
12/10/1998WO1998055604A1 Hydrophilic composition containing protease produced by vibrio
12/10/1998WO1998055600A2 New human ribonuclease
12/10/1998WO1998055510A2 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998WO1998055507A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998WO1998055499A1 11β-ARYL SUBSTITUTED 14,17-ETHANO-OESTRATRIENS, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS.
12/10/1998WO1998055498A1 17β-ALLYLOXY(THIO)ALKYL-ANDROSTANE DERIVATIVES FOR THE MODULATION OF MEIOSIS
12/10/1998WO1998055495A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
12/10/1998WO1998055483A1 PYRROLO[2,1,5-cd]INDOLIZINE DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
12/10/1998WO1998055481A1 Benzonaphthyridine
12/10/1998WO1998055480A1 Substituted 1h-pyridinyl-2-ones as gabaaalpha 2/3 ligands
12/10/1998WO1998055479A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055478A1 Novel phencyclidine derivatives, preparation methods and pharmaceutical compositions containing same
12/10/1998WO1998055475A1 Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
12/10/1998WO1998055474A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
12/10/1998WO1998055472A1 Coumarin derivatives, methods of preparation and application as medicines
12/10/1998WO1998055470A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055468A1 Oxazole compounds useful as pge2 agonists and antagonists
12/10/1998WO1998055453A1 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor
12/10/1998WO1998055439A1 Indane compounds and their pharmaceutical use
12/10/1998WO1998055132A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998WO1998055124A1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation
12/10/1998WO1998055121A1 Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome and gestational diabetes
12/10/1998WO1998055119A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055118A2 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
12/10/1998WO1998055116A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055115A1 Carboxamides useful as 5-ht1f agonists
12/10/1998WO1998055112A1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds
12/10/1998WO1998055106A1 Method for preparing pharmaceutical formulation
12/10/1998WO1998055075A2 Compositions and methods for inhibiting photoaging of skin
12/10/1998WO1998055074A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/10/1998WO1998054982A1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids
12/10/1998WO1998054966A1 A method of treating cancer
12/10/1998WO1998039429A3 Compositions for treatment of disorders involving programmed cell death
12/10/1998WO1998030590A3 Analogs of parathyroid hormone
12/10/1998CA2294547A1 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
12/10/1998CA2293693A1 Anti-gpiib/iiia recombinant antibodies
12/10/1998CA2292899A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292892A1 Translational regulator initiation factor 4e-binding protein
12/10/1998CA2292891A1 Zinc ring protein
12/10/1998CA2292881A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2292835A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292699A1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds
12/10/1998CA2292668A1 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/10/1998CA2292643A1 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998CA2292642A1 Novel phencyclidine derivatives, preparation methods and pharmaceutical compositions containing same
12/10/1998CA2292605A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2292536A1 Probiotic lactic acid bacterium to treat bacterial infections associated with sids
12/10/1998CA2292525A1 11.beta.-aryl substituted 14,17-ethano-oestratriens, method for the production of these compounds and their use in the production of medicaments
1 ... 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 ... 1564